- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 29.01. | Back to work | |
| 28.01. | AstraZeneca/Daiichi Sankyo's Enhertu granted FDA approval in breast cancer | |
| 28.01. | Roche/Sarepta announce two-year results for Duchenne muscular dystrophy gene therapy | |
| 28.01. | BMS presents promising data for immunotherapy combination in phase 3 colorectal cancer trial | |
| 28.01. | The silent treatment - researching gene silencing for Alzheimer's, Parkinson's and motor neurone disease | |
| 27.01. | Biogen/Eisai's Alzheimer's drug approved by FDA for monthly maintenance dosing | |
| 27.01. | Pfizer shares positive late-stage results for Braftovi regimen in colorectal cancer | |
| 27.01. | Havas Health Network launches Havas Life London | |
| 27.01. | Promiscuous strategists | |
| 24.01. | AbbVie and Neomorph enter molecular glue degrader partnership worth $1.64bn | |
| 24.01. | AstraZeneca/Daiichi Sankyo survey reveals breast cancer misconceptions in Europe | |
| 24.01. | UK drug repurposing study identifies several potential dementia treatments | |
| 24.01. | Creating and sustaining university biotech spin-outs | |
| 23.01. | WHO urges US to 'reconsider' withdrawal from global health organisation | |
| 23.01. | Takeda and EU Innovative Health Initiative launch Crohn's disease prevention study | |
| 23.01. | LEO pharma gains EU rights to Junshi Biosciences' PD-1 inhibitor toripalimab | |
| 23.01. | Unlocking innovation: how generative AI and data are reshaping healthcare marketing | |
| 22.01. | AstraZeneca receives NICE recommendations for lung cancer drugs Tagrisso and Imfinzi | |
| 22.01. | Sanofi's Sarclisa granted EC approval to treat newly diagnosed multiple myeloma | |
| 22.01. | Chiesi report highlights incorrect inhaler use among UK asthma patients | |
| 22.01. | The power of purpose | |
| 21.01. | WHO launches $1.5bn emergency appeal to tackle ongoing health crises | |
| 21.01. | Novo shares promising results for high-dose semaglutide in late-stage obesity study | |
| 21.01. | Valneva shares positive phase 3 results for chikungunya vaccine in adolescents | |
| 20.01. | AstraZeneca/Daiichi Sankyo's Datroway granted FDA approval in breast cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
